文献速递胸部肿瘤骨软组织肉瘤与黑色素瘤

MARK2/MARK3激酶是人类癌症中YAP/TAZ的催化性共依赖因子

MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer.
PubMed 文献 · Cancer Discov · 2024-01-01

该研究通过旁系同源基因共靶向CRISPR筛选发现,MARK2/3激酶是多种癌与肉瘤中YAP/TAZ功能的绝对催化需求;MARK2/3直接磷酸化NF2与YAP/TAZ,逆转LATS1/2的抑癌活性;将幽门螺杆菌CagA蛋白改造为MARK2/3催化抑制剂可在体内使已建立的肿瘤消退。

要点

  • MARK2/3是多种癌与肉瘤中YAP/TAZ功能的绝对催化性共依赖因子。
  • MARK2/3通过直接磷酸化NF2与YAP/TAZ逆转LATS1/2的抑癌活性。
  • 改造的CagA蛋白作为MARK2/3催化抑制剂可在体内使已建立肿瘤消退。

核心结论

  • MARK2/3是人类癌症中YAP/TAZ的强大共依赖因子,可能成为恢复Hippo通路介导肿瘤抑制的药理学靶点。

研究设计与样本

  • 采用旁系同源基因共靶向CRISPR筛选,在多种癌与肉瘤背景下鉴定MARK2/3为YAP/TAZ功能的绝对催化需求。

主要发现

  • MARK2/3依赖性地直接磷酸化NF2与YAP/TAZ,从而有效逆转Hippo模块激酶LATS1/2的肿瘤抑制活性。
  • 将幽门螺杆菌CagA蛋白改造为MARK2/3催化抑制剂,可在体内使已建立的肿瘤消退。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Hippo signaling pathway is commonly dysregulated in human cancer, which leads to a powerful tumor dependency on the YAP/TAZ transcriptional coactivators. In this study, we used paralog cotargeting CRISPR screens to identify kinases MARK2/3 as absolute catalytic requirements for YAP/TAZ function in diverse carcinoma and sarcoma contexts. Underlying this observation is the direct MARK2/3-dependent phosphorylation of NF2 and YAP/TAZ, which effectively reverses the tumor suppressive activity of the Hippo module kinases LATS1/2. To simulate targeting of MARK2/3, we adapted the CagA protein from Helicobacter pylori as a catalytic inhibitor of MARK2/3, which we show can regress established tumors in vivo. Together, these findings reveal MARK2/3 as powerful codependencies of YAP/TAZ in human cancer, targets that may allow for pharmacology that restores Hippo pathway-mediated tumor suppression. Significance: We show how genetic redundancy conceals tight functional relationships between signaling and transcriptional activation in cancer. Blocking the function of MARK2/3 kinases leads to the reactivation of the Hippo tumor suppressive pathway and may have therapeutic potential in YAP/TAZ-dysregulated carcinomas and sarcomas. See related commentary by Gauthier-Coles and Sheltzer, p. 2312.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Klingbeil O, Skopelitis D, Tonelli C, et al. MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer. Cancer Discov. 2024. PMID: 39058094. doi:10.1158/2159-8290.CD-23-1529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。